A major 20-year study that has found women using estrogen-only Hormone ReplacementTherapy (HRT) are at increased risk of ovarian cancer has important implications for Australian women, according to CEO of The Cancer Council NSW, Dr Andrew Penman.
"The study found the risk of ovarian cancer kept increasing the longer that women used the estrogen-only therapy," Dr Penman said.
"Previous studies into the link between estrogen-only HRT and ovarian cancer have been inconsistent, however this new study is very large, rigorous and accords with the results of other recent high quality research.
"Women should carefully consider their long-term use of estrogen-only HRT, and discuss their treatment with their doctor. While this study identifies the risks of estrogen-only therapy, more research is needed to determine the balance between the risks and the benefits of this treatment," he said.
This website and article is not a substitute for independent professional advice. Nothing contained in this website is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional's advice. All Health and any associated parties do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information.
